P3 Health Partners Profit Margin 2020-2025 | PIII
Current and historical gross margin, operating margin and net profit margin for P3 Health Partners (PIII) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. P3 Health Partners net profit margin as of June 30, 2025 is -9.99%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.055B | $1.500B |
| P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.674B | 59.39 |
| Tempus AI (TEM) | United States | $12.352B | 0.00 |
| Doximity (DOCS) | United States | $9.545B | 39.50 |
| Hims & Hers Health (HIMS) | United States | $8.883B | 72.26 |
| IRhythm Technologies (IRTC) | United States | $5.771B | 0.00 |
| Hinge Health (HNGE) | United States | $3.320B | 0.00 |
| Heartflow (HTFL) | United States | $2.981B | 0.00 |
| Privia Health (PRVA) | United States | $2.979B | 186.31 |
| Inspire Medical Systems (INSP) | United States | $2.642B | 43.71 |
| 10x Genomics (TXG) | United States | $2.078B | 0.00 |
| Enovis (ENOV) | United States | $1.787B | 9.38 |
| Omnicell (OMCL) | United States | $1.654B | 33.82 |
| Azenta (AZTA) | United States | $1.410B | 61.54 |
| Phreesia (PHR) | United States | $1.387B | 0.00 |
| Schrodinger (SDGR) | United States | $1.323B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.286B | 0.00 |
| Claritev (CTEV) | United States | $0.966B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.899B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.562B | 113.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Evolent Health (EVH) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.454B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.369B | 0.00 |
| Carlsmed (CARL) | United States | $0.328B | 0.00 |
| TruBridge (TBRG) | United States | $0.303B | 13.93 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.292B | 0.00 |
| CapsoVision (CV) | United States | $0.259B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.243B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.201B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.195B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.175B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| CareCloud (CCLD) | United States | $0.136B | 7.45 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.101B | 0.00 |
| Pulmonx (LUNG) | United States | $0.080B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |